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Editorial Policy
FEBS Letters is an international journal established for the rapid publication of short reports in the ¢eld of biochemistry, biophysics and molecular cell
biology. It provides a forum for reviews and research reports that merit urgent publication. FEBS Letters is published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
Papers should be short, but complete and essentially ¢nal reports. FEBS Letters is not a vehicle for publications of preliminary or fragmentary observations, or
for reports that are scienti¢cally sound but do not warrant urgent publication, or that are only addressed to a specialized readership. As a rule, we do not
publish the following: cloning and sequencing of a cDNA or a gene that has previously been reported for another species ; conventionally achieved expression
of a protein; incomplete NMR or other spectroscopic assignments; conventionally achieved crystallization of a protein; or just negative observations.
Methodological papers are normally not published, unless they are truly novel and signi¢cant. The overriding criterion is that a paper must be of su⁄cient
immediate importance to justify urgent publication
The subject area of FEBS Letters is broad. It covers biochemistry (including protein chemistry, enzymology, nucleic acid chemistry, metabolism, and
immunochemistry) structural biology, biophysics, computational biology (genomics, proteonomics, bioinformatics), molecular genetics, molecular biology
and molecular cell biology (signal transduction, intracellular tra⁄c, regulation of cellular proliferation, cell-cell interactions). Studies on microbes, plants and
animals at the molecular level are within the scope of FEBS Letters.
Extensive information on FEBS Letters including the contents of the journal is available via the internet at: http://www.elsevier.nl/febs. The full text of
published papers is available, however, only to those who are a⁄liated with libraries that have a subscription to FEBS Letters. For more information on
registration and site access, please see the internet address above.
The FEBS Letters web site also contains uncorrected proofs of papers in press. They are not intended for proof reading, but may provide a checkpoint for
major errors. The main reason for the publication of preprints is that they provide authors and readers with the newest research in press.
Submission Procedure
Please note that all articles must be submitted to the FEBS Letters Editorial O⁄ce at one of the following addresses :
Courier address: Postal address :
FEBS Letters Editorial O⁄ce FEBS Letters Editorial O⁄ce
European Molecular Biology Laboratory European Molecular Biology Laboratory
Meyerhofstr. 1 Postfach 102209
D-69117 Heidelberg D-69012 Heidelberg
Germany Germany
E-mail : FEBS.letters@EMBL-Heidelberg.de
Fax: (49)-6221-387 592
Tel. : (49)-6221-387 386
Note that if the handling Editor requires revisions, the authors should submit the revised manuscript directly to the Editor.
Papers must be submitted in English. Authors should include three self-addressed sticky labels and two extra copies of the title page and abstract with their
manuscript to facilitate editorial handling, and provide their fax and telephone numbers, and email address on the title page to enable the Editor/Publisher to contact
them on queries. Three copies of the paper should be submitted. The authors must also submit the paper in electronic form. This will accelerate the publication
process and reduce the danger of misprints.
Authors are also requested to provide the names and full addresses (including email) of 3 to 4 persons who are in the position to review their manuscript.
The ‘date of receipt’ appearing in the published paper will be the date when the Editor who actually handled the manuscript took receipt of it.
Submission of a paper to FEBS Letters implies that it has not been published in part nor is being considered elsewhere. We assume that the submitted
manuscript is approved by all authors. If this assumption turns out to be incorrect, the manuscript will be considered withdrawn, and will not be published.
Please note that our rejection procedure may take as long as in other journals. This is because the con¢rming opinion of a second Editor will always be
obtained before the paper is actually rejected. Authors may not re-submit to other Editorial Board Members a paper that has already been rejected.
Instructions for Electronic Submission
IURL: http://www.tetsubmit.com/febssubmit/show/
FEBSsubmit is an online submission environment. Authors can go to the website and upload their article as a Microsoft0 Word0 document.
The system generates an Adobe0 Acrobat0 PDF version of the article which is used for the reviewing process. Authors, reviewers and editors send and receive
all correspondence by e-mail and no paper correspondence is necessary.
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To upload your manuscript, you need:
1. A single ¢le representing your complete article in MS0 Word0 97 or MS0 Word0 98 for Macintosh0
2. Adobe0 Acrobat0 Reader version 3.01 or higher.
Introduction
FEBSsubmit is designed to allow authors to submit their manuscripts to FEBS Letters electronically. If you choose to submit electronically, do NOT submit
hard copies of your manuscript unless requested to do so by the Editorial O⁄ce or the handling Editor.
The system has three basic elements :
1. Your submission must be in MS0 Word0 6, MS0 Word0 97, or MS0 Word0 98 for Macintosh0 format. FEBSsubmit then turns this ¢le into a device- and
platform-independent PDF ¢le that can be approved by you online.
2. During the peer review process all manuscript transfers will be in PDF, because it is so easily readable and transferable. PDF-¢les can be read by using the
free Acrobat browser.
3. Please follow the normal instructions for FEBS Letters manuscripts. One change for electronic submission, however, is that you must have your article in
one ¢le. Graphics should be embedded (pasted) into your work document, and not submitted as separate ¢les.
The submission steps
On the submission form you will be asked to ¢ll in submission data and upload the ¢le. After this, the PDF-converter will produce a PDF ¢le, which you can
view to see if everything is in order (please note that the article will have a di¡erent appearance in the journal). After this, please go through the various screens
of FEBSsubmit, and duly follow the instructions.
What happens after submission?
After you completed your submission, the FEBS Letters Editorial O⁄ce in Heidelberg will receive your article and submission data by e-mail. They will notify
receipt within three working days. After an initial editorial screening, the o⁄ce will then e-mail the article to one of the 30 editors for further handling of the
paper.
Our production process requires original hard copy (i.e. printed on paper) artwork (line drawings, photographs). Therefore, if your manuscript is accepted for
publication, you will be asked to send your article to the Editor in the usual way: by traditional mail with a hard-copy print of the text, and separate hard-
copies of your ¢gures suitable for direct reproduction, as well as a disk with your paper in Word.
The prime reason for this retrograde-seeming last step is that in most cases the artwork in electronic form will be of too low resolution for printers, who require
1200 dpi rather than the screen resolution of 72 dpi. We are working on a ¢nal electronic submission step for all source ¢les.
This electronic peer review environment is expected to reduce the evaluation period an extra one to two weeks. In combination with the fast production time of
one week, FEBS Letters will be able to publish manuscripts on-line within four weeks or less.
Minireviews and Hypotheses
The Minireviews should be topical and of interest not only to specialists in the ¢eld but also to the general reader. Su⁄cient information should, therefore, be
included in the Introduction to provide background to non-specialists. They should, as a rule, be not more than 2500 words in length, have preferably not more
than 50 references and 3 ¢gures or tables. They should contain at least one ¢gure, scheme or table that illustrates a central aspect of the review. A short abstract
(less than 100 words) and 4^6 key words should be included. The author(s) should use short descriptive subtitles. Papers labeled as ‘Hypothesis’ should present
novel ideas or new interpretations of established observations, but should be based on sound data and avoid excessive speculation (please note that preliminary
experiments cannot be published as a hypothesis). Personal views and snappy ideas can also be expressed in Minireviews that can even be provocative.
Since the majority of Minireviews and Hypotheses are now being solicited, authors wishing to submit such manuscripts should email the FEBS Letters
Editorial O⁄ce prior to submission, providing a title and abstract of the article to be considered.
Correspondence
Authors may submit Correspondence regarding manuscripts published in FEBS Letters or any other relevant matter. If submitted Correspondence directly
criticizes a recent paper published in FEBS Letters, the authors of the original manuscript will be allowed to respond.
Correspondence should be limited to 4 typed, double-spaced pages of text and a maximum of one ¢gure and 5 references. Correspondence should be written in
the format of a letter, without an abstract and without de¢ned Introduction, Material and Methods, Results, or Discussion sections. A short title, followed by
the authors’ names should be at the beginning of the Correspondence and the authors’ a⁄liations should be placed in a footnote at the end of the text. FEBS
Letters reserves the right to edit any submitted Correspondence for length and clarity.
General Arrangement of Research Letters
The ¢rst page should carry the title, authors’ names and a⁄liations (with full postal addresses, telephone and fax numbers, and E-mail address), an abstract, up
to six speci¢c key words and appropriate footnotes, indicating the corresponding author, and a list of abbreviations. The abstract should be less than 100
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words and summarize the question being addressed and the pertinent ¢ndings; the key words should re£ect signi¢cant factors of the investigation as a whole.
On subsequent pages, the Introduction (1.) should be followed by numbered sections: 2. Materials and Methods, or 2. Experimental ; 3. Results ; 4. Discussion.
When appropriate, Results and Discussion sections may be combined. Acknowledgements should precede References and not be included as a footnote.
Figure legends and tables should appear on separate sheets after References.
The length of the submitted manuscript should be such that the ¢nal printed version does not exceed 5 pages, including the ¢gure legends, tables and references (ca.
16,000 characters or 3000 words). The Editors will only accept longer papers when there are compelling reasons. Any repetition of information in the text and
¢gures should be avoided.
Manuscripts must be typewritten, double-spaced with wide margins, on one side of the paper only.
The Title should be a maximum of two printed lines in the journal (140 characters, including spaces). Active titles are preferred. Technical terms, such as
‘cloning’, ‘expression’, ‘puri¢cation’ and specialized abbreviations should be avoided. Titles should not be repetitive but state in a clear and concise manner the
basis of the manuscript. The Editorial O⁄ce reserves the right to edit titles for length and clarity.
The original manuscript and ¢gures, plus two complete copies, should be submitted to facilitate refereeing. Unless requested otherwise, only the top copy of the
manuscript will be returned to the author if a paper is rejected.
Papers may be returned to authors for revision. Revised versions returned more than four weeks after receipt of reviewers’ comments will be considered as
resubmissions and will carry only the date of receipt of the revised version. Revised manuscripts should be submitted directly to the handling Editor.
The author(s) for correspondence and full postal address should be indicated in a footnote on the title page, along with e-mail address and telephone and fax
numbers.
Key words : Authors are requested to consult the annual cumulative subject index of FEBS Letters or the list of subject headings from Index Medicus for
preferred synonyms and standard abbreviations. A maximum of six key words should be selected and included with the submitted manuscript. American
English spelling will be used and plural terms avoided where possible. The list submitted may be amended to ensure that index entries are consistent in the
master index. General terms such as enzyme, membrane, etc. should not be used unless quali¢ed, e.g. membrane phosphorylation, enzyme activation.
Example:
Game, S., Holman, G. and Eisenthal, R. (1986) FEBS Lett. 194, 126-130.
Title: Sugar transport in Trypanosoma brucei : a suitable kinetic probe
Key words: Sugar transport; D-Glucose; Anhydro-D-glucitol, 1,5- ; Deoxy-D-glucose; Trypanosoma brucei
Nomenclature and abbreviations : Authors should follow internationally agreed rules as set out in ‘‘Biochemical Nomenclature and Related Documents’’ (A
Compendium, 2nd edition, 1992) International Union of Biochemistry and Molecular Biology, published by Portland Press, London and Chapel Hill, UK.
Abbreviations should be expanded in a footnote on the title page.
Tables : Tables should be used only when the data cannot be presented clearly in the text. Authors are requested to consult recent issues of FEBS Letters for the
proper table layout. The heading of the table should make its general meaning understandable without reference to the text.
References : These will be numbered in square brackets, e.g. [7], or [11-13,17], in order of citation in the text. The list of references will be printed at the end of
the paper. References to journal articles should contain the names and initials of all authors, year of publication in parentheses, abbreviation of the journal title
according to current practice, volume number and inclusive page numbers. Articles may be cited as ‘in press’ only if a copy of the acceptance notice is supplied
at the time of submission. References to books should include the names and initials of the author(s), year of publication, title of the book, name and initials of
editor(s) in parentheses, volume, edition, inclusive page numbers, and name and location of the publisher. No part of the references should be underlined;
’and’ should be used instead of ‘p’ ; authors’ surnames should always be in lower case and precede authors’ initials. Citations as ‘unpublished’ and ‘personal
communication’ should be placed in the main text.
As noted below, when preparing your manuscript, please do not use an automated referencing system.
Examples of journals [1] and books [2,3] :
[1] Diller, R., Stockburger, M., Oesterhelt, D. and Tittor, J. (1987) FEBS Lett. 217, 297-304.
[2] Gomperts, B.D. and Fewtrell, C.M.S. (1985) in: Molecular Mechanisms of Transmembrane Signalling (Cohen, P. and Houslay, M.D., Eds.) Mol. Aspects
Cell. Regul. vol. 4, pp. 377-409, Elsevier, Amsterdam, New York.
[3] Robson, B. and Garnier, J. (1986) Introduction to Proteins and Protein Engineering, Elsevier, Amsterdam, New York.
Electronic Manuscript : The publisher can use ¢les produced with most commercial word-processing software (but ideally WordPerfect or Microsoft Word)
preferably saved on a 3.5-inch ‘£oppy’ disk. MS-DOS or Apple Macintosh systems are suitable, but in the latter case, do not use the options ‘save in MS-DOS
format’, ‘save as ASCII’, or similar. These cause the formatting to be lost. Please do not split the article into separate ¢les ; only one text ¢le (the complete
article) should be on the disk.
Consistency in all operations is essential when preparing your manuscript. Some further guidelines follow:
b Do not use (or allow your word-processor to introduce) any of the following: hyphenation, justi¢cation, automated numbering of references or tracking
changes.
b Avoid incorporating equations as ‘pictures’ or ‘OLE objects’ in the text. Please use the ‘equation editor’ provided by your word processing software.
b Authors should ensure that the digit ‘1’ and the letter ‘l’ (also the digit ‘0’ and the letter ‘O’) have been used properly. The letter X and the ‘times’ sign, the
apostrophe and the prime, and the hyphen and ‘en’ dash are further sources of confusion. Please check these carefully.
b Any special characters (eg, umlauts, accents, Greek characters and mathematical symbols) should be used consistently throughout the text. Characters that
you have di⁄culty reproducing should not be left as blanks, but should be replaced by another character (not used elsewhere in the text) and a key to such
substitutions should be included as a note to the typesetter.
b Expressions in Latin (eg, in vivo, per se, vide supra) should not be italicized or underlined.
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b Output from desktop publishing software contains extra coding which interferes with normal ¢le processing. Such DTP output should be avoided.
b Please label the disk with the soft- and hardware used and the names of the ¢les.
The electronic ¢le must be the ¢nal, corrected version of the article, including all revisions, and must exactly match the printed version. Please pay particular
attention to ¢gures and references, any discrepancies between hardcopy and electronic ¢le jeopardize the safe handling of your paper. The Publisher is under
no obligation to use the submitted disk, but will make every attempt to ensure that it is used.
Preparation of Figures
All ¢gures should be designed to economize on space, and ideally should be made to ¢t one printed column (width 8 cm). They should be provided in the size
they are going to eventually appear in print. Whenever possible, ¢gures will be returned if this is requested when the manuscript is submitted.
Nucleic acid and deduced protein sequences are published only when there is a special need to do so; instead, database accession numbers should be given.
Authors wishing to show detailed sequences, alignments, or other such ¢gures may annex that data to the Web version of the article.
Original ¢gures should be of su⁄ciently high quality with respect to detail, contrast, and sharpness. For detailed instructions regarding the production of high
quality ¢gures, please visit Elsevier’s guide to electronic artwork at http://www.elsevier.nl/locate/authorartwork
Color reproduction: When these are essential to the understanding of a paper, ¢gures may be reproduced in color. The price of a single printed full color page
is D£. 750.00, exclusive of sales tax. Two, three or four full color pages in combination will cost D£. 500.00 per page plus sales tax.
For electronic versions of ¢gures, please note the following:
b Do not use screen images from, for example, the internet. These are of the wrong format and are of insu⁄cient resolution.
b Avoid embedding images in the text ¢le. Images should always be enclosed as separate ¢les.
b Always include a high-quality hardcopy of the ¢gure with the manuscript.
b Avoid formats such as: GIF, BMP, PICT, WPG and DOC.
b Acceptable ¢le formats are: EPS, JPEG and TIFF. For EPS ¢les, always enclose the font; for JPEG color and grayscale ¢les, 300dpi is a minimum
resolution (for JPEG combination ¢les, or line pictures, 500dpi is required); for TIFF ¢les, a minimum of 600dpi is required, and more may be necessary for
very ¢ne reproduction.
b Color images should always be CMYK, not RGB.
b For speci¢c enquiries on the preparation of electronic artwork, consult http://www.elsevier.com/locate/authorartwork/
Publication of Macromolecular Structures
FEBS Letters recognizes the guidelines and recommendations made by the International Union of Crystallography. We wish to ensure that structural data are
deposited and freely available for the scienti¢c community. All publications that describe macromolecular three-dimensional structures at the level of atomic
positions must be accompanied by deposition of atomic coordinates and preferably also structure-factor amplitudes in the appropriate database (PDB or
NDP). In the case of low-resolution structures, a set of Cb positions may be su⁄cient. An article that reports a three-dimensional structure will not be ¢nally
accepted until the relevant entry codes have been provided. The authors are urged to release the atomic parameters immediately after the publication date. If a
delay in their release is requested (not longer than six months), the authors need to follow the policies imposed by the database managers.
Ethics of Experimentation
In scienti¢c investigations involving humans, the steps taken to avoid unjusti¢ed risk or discomfort should be stated. These should include peer review of the
proposed investigation and informed consent by the subjects being investigated. Similarly, the steps taken to protect animals from pain should be stated
explicitly.
Proofs
Proofreading is the publisher’s responsibility. Therefore, typescripts should be carefully checked before submission to obviate alterations after acceptance.
Only when speci¢cally requested on the title page at the time of submission and endorsed by the accepting Editor on the acceptance form, will proofs be faxed to the
authors to check for minor errors; response within 24 hours is a MUST.
If the authors wish to introduce extensive changes (at the issue manager’s discretion) the proofs will be sent to the accepting Editor and be treated as a revised
version. Amendments requiring this extra procedure at the proof stage may thus delay the appearance of the paper by some weeks.
As noted on the FEBS Letters homepage, http://www.elsevier.nl/febs, copies of articles in press are uncorrected, and are not intended the proo¢ng purposes.
By the time prepress proofs are posted on the site, the correction process is already underway. In due course these proofs are replaced with the printed version.
Requests for Permission to Reproduce Material from Published Articles
Authors who wish to reproduce ¢gures, tables and text from articles published in FEBS Letters for non-commercial purposes may do so, providing the original
publication is acknowledged accordingly and the authors’ approval is obtained. No special permission is needed from either the Publisher or the Managing
Editor for this.
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Reprints
Upon acceptance of a paper the submitting author will receive an order form on which all authors’ reprints of that article may be ordered, including the 50 free
reprints. In addition, the author should supply missing or supplementary material as requested. The intact reprint order form should be returned as soon as
possible to: FEBS Letters, Log-In Dept., Elsevier Science BV, PO Box 2759, 1000 CT Amsterdam, the Netherlands.
Publication Matters
Address all queries concerning accepted manuscripts to: FEBS Letters, Log-In Dept., Elsevier Science BV, PO Box 2759, 1000 CT Amsterdam, The Nether-
lands (Fax: (31)-20-485 3271; e-mail : m.bouayad@elsevier.nl), specifying the Editor’s code and manuscript number.
Press releases : Authors who wish to issue a press release on some of their material which has been accepted by us, can do so whenever they want to. However,
the best time for a press release is after completion of the typesetting of the issue, i.e., usually about two weeks before the dispatch date. Only then is the correct
and complete reference known. The initiative of a press release may be taken by the handling Editor, who will get in touch with the authors and with the
Managing Editor for this purpose.
Other enquiries
For enquiries relating to the status of accepted articles through our Online Article Status Information System (OASIS), author Frequently Asked Questions
and any other enquiries relating to Elsevier Science, please consult http://www.elsevier.com/locate/authors/
Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided when an article is accepted for publication.
Sequence Data Submission and Accession Numbers
Authors must be aware that all new nucleotide sequence data must be submitted together with a completed data submission form to the EMBL Nucleotide
Sequence Database. The database accession-number is included in the manuscript.
Nucleotide sequence data reported in FEBS Letters with an EMBL Nucleotide Sequence Database accession number can be retrieved electronically by sending
commands to a File Server at the European Bioinformatics Institute (NETSERV@EBI.AC.UK).
Copyright z 1996-2000, Federation of European Biochemical Societies. All rights reserved.
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